DEMINERALIZED BONE MATRIX MARKET ANALYSIS

Demineralized Bone Matrix Market, By Product Type (Putty, Gel, Paste, Strips/Sheets, and Others), By Tissue Source (Allograft, and Xenograft), By Application (Spinal Fusion, Trauma, Foot and Ankle, Dental, and Other Applications), By End User (Hospitals, Orthopedic Clinics, Academic and Research Institutes, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In October 2022, Orthofix Medical Inc has announced the full market release and first implants of Legacy Demineralized Bone Matrix (DBM), a putty used to fill voids or gaps in boney defects or traumatic injuries in the spine, pelvis, or extremities. Processed by MTF Biologics, Legacy DBM retains natural growth factors essential for bone healing.
In October 2022, Paragon 28 Inc. introduced the V92-FC+ Cellular Bone Matrix, a moldable allograft matrix containing primitive cells, specifically designed for addressing bone defects and remodeling in the foot and ankle.
In September 2021 Essent Biologics, a nonprofit biotechnology company, launched its spectral demineralized bone matrix (DBM), the first human-derived DBM specifically designed for 3D bioprinting and tissue engineering research. This DBM powder, derived from adult human cortical bone, offers osteoconductive properties with osteoinductive potential.